GE HealthCare Technologies Inc. $GEHC Shares Bought by ProShare Advisors LLC

ProShare Advisors LLC grew its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 7.4% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 724,856 shares of the company’s stock after purchasing an additional 49,924 shares during the period. ProShare Advisors LLC owned approximately 0.16% of GE HealthCare Technologies worth $53,690,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of the company. N.E.W. Advisory Services LLC purchased a new position in GE HealthCare Technologies in the first quarter valued at approximately $25,000. Bogart Wealth LLC increased its position in shares of GE HealthCare Technologies by 260.0% in the first quarter. Bogart Wealth LLC now owns 342 shares of the company’s stock worth $28,000 after acquiring an additional 247 shares in the last quarter. Gladwyn Financial Advisors Inc. acquired a new stake in shares of GE HealthCare Technologies in the second quarter worth $34,000. Game Plan Financial Advisors LLC raised its stake in shares of GE HealthCare Technologies by 295.3% in the 2nd quarter. Game Plan Financial Advisors LLC now owns 502 shares of the company’s stock valued at $37,000 after acquiring an additional 375 shares during the period. Finally, Zions Bancorporation National Association UT acquired a new position in shares of GE HealthCare Technologies during the 1st quarter valued at $42,000. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Analyst Upgrades and Downgrades

GEHC has been the subject of several recent research reports. Weiss Ratings reiterated a “hold (c+)” rating on shares of GE HealthCare Technologies in a report on Tuesday, October 14th. Zacks Research lowered GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 29th. BTIG Research set a $87.00 target price on GE HealthCare Technologies in a report on Wednesday, October 29th. Citigroup cut GE HealthCare Technologies from a “buy” rating to a “neutral” rating and decreased their price target for the stock from $93.00 to $83.00 in a report on Tuesday, October 7th. Finally, Barclays started coverage on shares of GE HealthCare Technologies in a research report on Monday, October 13th. They issued an “equal weight” rating and a $86.00 price objective for the company. Six analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $86.10.

GE HealthCare Technologies Stock Performance

Shares of GEHC opened at $73.48 on Tuesday. The firm has a market cap of $33.47 billion, a price-to-earnings ratio of 15.18, a PEG ratio of 2.75 and a beta of 1.13. The company has a quick ratio of 0.95, a current ratio of 1.18 and a debt-to-equity ratio of 0.83. The business’s 50 day moving average is $75.11 and its two-hundred day moving average is $73.60. GE HealthCare Technologies Inc. has a 52-week low of $57.65 and a 52-week high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.05 by $0.02. The business had revenue of $5.14 billion during the quarter, compared to analyst estimates of $5.07 billion. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The business’s revenue was up 5.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.14 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. Analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 24th will be issued a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend is Friday, October 24th. GE HealthCare Technologies’s payout ratio is currently 2.89%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.